Ranking · Trend
Publication growth
Ratio of publications in the last 12 months to the average annual publications over the preceding 5-year window. Values above 1 indicate accelerating literature.
Computedci-pub-growth-v1unit: ratiohigher is first (neutral)All metrics
| Rank | Δ | Cancer | Publication growth (ratio) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Acute Biphenotypic Leukemia | 2.59 | 100 | Medium confidence | pubmed | inputs
ranking row 2591172 |
| 2 | = | Extranodal Lymphoma | 2.25 | 99.6 | Medium confidence | pubmed | inputs
ranking row 2591173 |
| 3 | = | Childhood Lymphoma | 2.14 | 99.3 | Medium confidence | pubmed | inputs
ranking row 2591174 |
| 4 | = | Systemic Mastocytosis with an Associated Myeloid Neoplasm | 2.12 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2591175 |
| 5 | = | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 1.9 | 98.6 | Medium confidence | pubmed | inputs
ranking row 2591176 |
| 6 | = | Childhood Acute Leukemia | 1.88 | 98.2 | Medium confidence | pubmed | inputs
ranking row 2591177 |
| 7 | = | Lung Mucosa-Associated Lymphoid Tissue Lymphoma | 1.85 | 97.9 | Medium confidence | pubmed | inputs
ranking row 2591178 |
| 8 | = | Intestinal Lymphoma | 1.83 | 97.5 | Medium confidence | pubmed | inputs
ranking row 2591179 |
| 9 | = | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1.79 | 97.2 | Medium confidence | pubmed | inputs
ranking row 2591180 |
| 10 | = | Extranodal Non-Hodgkin Lymphoma | 1.79 | 96.8 | Medium confidence | pubmed | inputs
ranking row 2591181 |
| 11 | = | Aggressive B-Cell Non-Hodgkin Lymphoma | 1.78 | 96.5 | Medium confidence | pubmed | inputs
ranking row 2591182 |
| 12 | = | T Lymphoblastic Leukemia/Lymphoma | 1.78 | 96.1 | Medium confidence | pubmed | inputs
ranking row 2591183 |
| 13 | = | Lung Lymphoma | 1.77 | 95.8 | Medium confidence | pubmed | inputs
ranking row 2591184 |
| 14 | = | Primary Vitreoretinal Non-Hodgkin Lymphoma | 1.77 | 95.4 | Medium confidence | pubmed | inputs
ranking row 2591185 |
| 15 | = | Hereditary Malignant Neoplasm | 1.75 | 95.1 | Medium confidence | pubmed | inputs
ranking row 2591186 |
| 16 | = | Orbital Lymphoma | 1.73 | 94.7 | Medium confidence | pubmed | inputs
ranking row 2591187 |
| 17 | = | Prefibrotic Primary Myelofibrosis | 1.7 | 94.4 | Medium confidence | pubmed | inputs
ranking row 2591188 |
| 18 | = | Digestive System Lymphoma | 1.68 | 94 | Medium confidence | pubmed | inputs
ranking row 2591189 |
| 19 | = | B Lymphoblastic Leukemia/Lymphoma | 1.61 | 93.7 | Medium confidence | pubmed | inputs
ranking row 2591190 |
| 20 | = | Low-grade Appendiceal Mucinous Neoplasm | 1.61 | 93.3 | Medium confidence | pubmed | inputs
ranking row 2591191 |
| 21 | = | Acute Leukemia of Ambiguous Lineage | 1.59 | 93 | Medium confidence | pubmed | inputs
ranking row 2591192 |
| 22 | = | Mixed Phenotype Acute Leukemia | 1.56 | 92.6 | Medium confidence | pubmed | inputs
ranking row 2591193 |
| 23 | = | Aggressive Adult Non-Hodgkin Lymphoma | 1.56 | 92.3 | Medium confidence | pubmed | inputs
ranking row 2591194 |
| 24 | = | Acute Myeloid Leukemia, Myelodysplasia-Related | 1.55 | 91.9 | Medium confidence | pubmed | inputs
ranking row 2591195 |
| 25 | = | Somatic-Type Malignancy | 1.55 | 91.6 | Medium confidence | pubmed | inputs
ranking row 2591196 |
| 26 | = | Occupational Malignant Neoplasm | 1.54 | 91.2 | Medium confidence | pubmed | inputs
ranking row 2591197 |
| 27 | = | Adult Classic Hodgkin Lymphoma | 1.51 | 90.9 | Medium confidence | pubmed | inputs
ranking row 2591198 |
| 28 | = | Adult T Lymphoblastic Lymphoma | 1.51 | 90.5 | Medium confidence | pubmed | inputs
ranking row 2591200 |
| 28 | = | Childhood T Lymphoblastic Lymphoma | 1.51 | 90.5 | Medium confidence | pubmed | inputs
ranking row 2591199 |
| 30 | = | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | 1.51 | 89.8 | Medium confidence | pubmed | inputs
ranking row 2591201 |
| 31 | = | Malignant Nervous System Neoplasm | 1.51 | 89.5 | Medium confidence | pubmed | inputs
ranking row 2591202 |
| 32 | = | Grade 1 Follicular Lymphoma | 1.51 | 89.1 | Medium confidence | pubmed | inputs
ranking row 2591203 |
| 33 | = | Atypical Lipomatous Tumor | 1.5 | 88.8 | Medium confidence | pubmed | inputs
ranking row 2591204 |
| 34 | = | Lymphoplasmacytic Lymphoma | 1.5 | 88.4 | Medium confidence | pubmed | inputs
ranking row 2591205 |
| 35 | = | T Lymphoblastic Lymphoma | 1.49 | 88.1 | Medium confidence | pubmed | inputs
ranking row 2591206 |
| 36 | = | Grade 3 Follicular Lymphoma | 1.49 | 87.7 | Medium confidence | pubmed | inputs
ranking row 2591207 |
| 37 | = | Plasmacytoid Dendritic Cell Neoplasm | 1.48 | 87.4 | Medium confidence | pubmed | inputs
ranking row 2591208 |
| 38 | = | Small Lymphocytic Lymphoma | 1.47 | 87 | Medium confidence | pubmed | inputs
ranking row 2591209 |
| 39 | = | Grade 2 Follicular Lymphoma | 1.47 | 86.7 | Medium confidence | pubmed | inputs
ranking row 2591210 |
| 40 | = | Extraosseous Plasmacytoma | 1.45 | 86.3 | Medium confidence | pubmed | inputs
ranking row 2591211 |
| 41 | = | Classic Hodgkin Lymphoma | 1.44 | 86 | Medium confidence | pubmed | inputs
ranking row 2591212 |
| 42 | = | Aggressive NK-Cell Leukemia | 1.43 | 85.6 | Medium confidence | pubmed | inputs
ranking row 2591214 |
| 42 | = | Malignant Germ Cell Tumor | 1.43 | 85.6 | Medium confidence | pubmed | inputs
ranking row 2591213 |
| 44 | = | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 1.43 | 84.9 | Medium confidence | pubmed | inputs
ranking row 2591215 |
| 45 | = | Lung Intravascular Large B-Cell Lymphoma | 1.41 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2591216 |
| 46 | = | Rare Childhood Malignant Neoplasm | 1.41 | 84.2 | Medium confidence | pubmed | inputs
ranking row 2591217 |
| 47 | = | Solid Pseudopapillary Neoplasm | 1.4 | 83.9 | Medium confidence | pubmed | inputs
ranking row 2591218 |
| 48 | = | High Grade B-Cell Lymphoma | 1.4 | 83.5 | Medium confidence | pubmed | inputs
ranking row 2591219 |
| 49 | = | Non-Seminomatous Germ Cell Tumor | 1.4 | 83.2 | Medium confidence | pubmed | inputs
ranking row 2591220 |
| 50 | = | Obesity-Related Malignant Neoplasm | 1.39 | 82.8 | Medium confidence | pubmed | inputs
ranking row 2591221 |
| 51 | = | Leukemia Cutis | 1.39 | 82.5 | Medium confidence | pubmed | inputs
ranking row 2591222 |
| 52 | = | Secondary Acute Myeloid Leukemia | 1.38 | 82.1 | Medium confidence | pubmed | inputs
ranking row 2591223 |
| 53 | = | Aggressive Non-Hodgkin Lymphoma | 1.37 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2591224 |
| 54 | = | Undifferentiated Embryonal Sarcoma of the Liver | 1.36 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2591225 |
| 55 | = | Endemic Burkitt Lymphoma | 1.36 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2591226 |
| 56 | = | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1.36 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2591227 |
| 57 | = | Malignant Uterine Corpus Neoplasm | 1.35 | 80.4 | Medium confidence | pubmed | inputs
ranking row 2591228 |
| 58 | = | Childhood Malignant Neoplasm | 1.35 | 80 | Medium confidence | pubmed | inputs
ranking row 2591229 |
| 59 | = | Ocular Adnexal Non-Hodgkin Lymphoma | 1.35 | 79.6 | Medium confidence | pubmed | inputs
ranking row 2591230 |
| 60 | = | Acute Undifferentiated Leukemia | 1.34 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2591231 |
| 61 | = | Adult B Lymphoblastic Lymphoma | 1.33 | 78.9 | Medium confidence | pubmed | inputs
ranking row 2591233 |
| 61 | = | Childhood B Lymphoblastic Lymphoma | 1.33 | 78.9 | Medium confidence | pubmed | inputs
ranking row 2591232 |
| 63 | = | Mycosis Fungoides and Sezary Syndrome | 1.33 | 78.2 | Medium confidence | pubmed | inputs
ranking row 2591234 |
| 64 | = | Myeloid Leukemia Associated with Down Syndrome | 1.33 | 77.9 | Medium confidence | pubmed | inputs
ranking row 2591235 |
| 65 | = | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | 1.32 | 77.5 | Medium confidence | pubmed | inputs
ranking row 2591236 |
| 66 | = | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1.32 | 77.2 | Medium confidence | pubmed | inputs
ranking row 2591238 |
| 66 | = | Myeloproliferative Neoplasm, Not Otherwise Specified | 1.32 | 77.2 | Medium confidence | pubmed | inputs
ranking row 2591237 |
| 68 | = | B Acute Lymphoblastic Leukemia | 1.32 | 76.5 | Medium confidence | pubmed | inputs
ranking row 2591239 |
| 69 | = | Malignant Hypopharyngeal Neoplasm | 1.31 | 76.1 | Medium confidence | pubmed | inputs
ranking row 2591240 |
| 70 | = | Breast Lymphoma | 1.31 | 75.8 | Medium confidence | pubmed | inputs
ranking row 2591241 |
| 70 | = | Primary Mediastinal Large B-Cell Lymphoma | 1.31 | 75.8 | Medium confidence | pubmed | inputs
ranking row 2591242 |
| 72 | = | Cystadenocarcinoma | 1.3 | 75.1 | Medium confidence | pubmed | inputs
ranking row 2591243 |
| 73 | = | Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type | 1.3 | 74.7 | Medium confidence | pubmed | inputs
ranking row 2591244 |
| 74 | = | Childhood Acute Myeloid Leukemia | 1.3 | 74.4 | Medium confidence | pubmed | inputs
ranking row 2591245 |
| 75 | = | Adult Acute Myeloid Leukemia | 1.3 | 74 | Medium confidence | pubmed | inputs
ranking row 2591246 |
| 76 | = | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1.29 | 73.7 | Medium confidence | pubmed | inputs
ranking row 2591247 |
| 77 | = | Adult Acute Megakaryoblastic Leukemia | 1.29 | 73.3 | Medium confidence | pubmed | inputs
ranking row 2591248 |
| 78 | = | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1.29 | 73 | Medium confidence | pubmed | inputs
ranking row 2591249 |
| 79 | = | Folliculotropic Mycosis Fungoides | 1.28 | 72.6 | Medium confidence | pubmed | inputs
ranking row 2591250 |
| 80 | = | Malignant Digestive System Neoplasm | 1.28 | 72.3 | Medium confidence | pubmed | inputs
ranking row 2591251 |
| 81 | = | Intestinal T-Cell Lymphoma | 1.28 | 71.9 | Medium confidence | pubmed | inputs
ranking row 2591252 |
| 82 | = | Intravascular Large B-Cell Lymphoma | 1.28 | 71.6 | Medium confidence | pubmed | inputs
ranking row 2591253 |
| 83 | = | Malignant Anal Neoplasm | 1.28 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2591254 |
| 84 | = | Solitary Plasmacytoma | 1.27 | 70.9 | Medium confidence | pubmed | inputs
ranking row 2591255 |
| 85 | = | Intraductal Papillary Neoplasm of the Bile Duct | 1.27 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2591256 |
| 86 | = | Grade 3a Follicular Lymphoma | 1.26 | 70.2 | Medium confidence | pubmed | inputs
ranking row 2591257 |
| 87 | = | Childhood Acute Megakaryoblastic Leukemia | 1.26 | 69.8 | Medium confidence | pubmed | inputs
ranking row 2591258 |
| 88 | = | Nodular Sclerosis Classic Hodgkin Lymphoma | 1.26 | 69.5 | Medium confidence | pubmed | inputs
ranking row 2591259 |
| 89 | = | Malignant Cervical Neoplasm | 1.26 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2591260 |
| 90 | = | Adult Systemic Anaplastic Large Cell Lymphoma | 1.25 | 68.8 | Medium confidence | pubmed | inputs
ranking row 2591262 |
| 90 | = | Systemic Anaplastic Large Cell Lymphoma | 1.25 | 68.8 | Medium confidence | pubmed | inputs
ranking row 2591261 |
| 92 | = | Central Nervous System Lymphoma | 1.24 | 68.1 | Medium confidence | pubmed | inputs
ranking row 2591263 |
| 93 | = | Childhood Burkitt Lymphoma | 1.24 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2591264 |
| 94 | = | Marginal Zone Lymphoma | 1.24 | 67.4 | Medium confidence | pubmed | inputs
ranking row 2591265 |
| 95 | = | Malignant Lung Neoplasm | 1.24 | 67 | Medium confidence | pubmed | inputs
ranking row 2591266 |
| 96 | = | Adult Burkitt Lymphoma | 1.24 | 66.7 | Medium confidence | pubmed | inputs
ranking row 2591267 |
| 97 | = | B Lymphoblastic Lymphoma | 1.23 | 66.3 | Medium confidence | pubmed | inputs
ranking row 2591268 |
| 98 | = | Adult Acute Lymphoblastic Leukemia | 1.23 | 66 | Medium confidence | pubmed | inputs
ranking row 2591269 |
| 99 | = | Adult Lymphoblastic Lymphoma | 1.23 | 65.6 | Medium confidence | pubmed | inputs
ranking row 2591271 |
| 99 | = | Childhood Lymphoblastic Lymphoma | 1.23 | 65.6 | Medium confidence | pubmed | inputs
ranking row 2591272 |
| 99 | = | Lymphoblastic Lymphoma | 1.23 | 65.6 | Medium confidence | pubmed | inputs
ranking row 2591270 |
| 102 | = | Malignant Bladder Neoplasm | 1.23 | 64.6 | Medium confidence | pubmed | inputs
ranking row 2591273 |
| 103 | = | Indolent Non-Hodgkin Lymphoma | 1.23 | 64.2 | Medium confidence | pubmed | inputs
ranking row 2591274 |
| 104 | = | Malignant Pancreatic Neoplasm | 1.23 | 63.9 | Medium confidence | pubmed | inputs
ranking row 2591275 |
| 105 | = | Core Binding Factor Acute Myeloid Leukemia | 1.23 | 63.5 | Medium confidence | pubmed | inputs
ranking row 2591276 |
| 106 | = | Malignant Gallbladder Neoplasm | 1.22 | 63.2 | Medium confidence | pubmed | inputs
ranking row 2591277 |
| 107 | = | Adult Diffuse Large B-Cell Lymphoma | 1.22 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2591278 |
| 107 | = | Childhood Diffuse Large B-Cell Lymphoma | 1.22 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2591279 |
| 109 | = | Central Nervous System Leukemia | 1.22 | 62.1 | Medium confidence | pubmed | inputs
ranking row 2591280 |
| 110 | = | Diffuse Large B-Cell Lymphoma | 1.22 | 61.8 | Medium confidence | pubmed | inputs
ranking row 2591281 |
| 111 | = | Malignant Breast Neoplasm | 1.21 | 61.4 | Medium confidence | pubmed | inputs
ranking row 2591282 |
| 112 | = | Primary Central Nervous System Lymphoma | 1.21 | 61.1 | Medium confidence | pubmed | inputs
ranking row 2591283 |
| 113 | = | Malignant Prostate Neoplasm | 1.21 | 60.7 | Medium confidence | pubmed | inputs
ranking row 2591284 |
| 114 | = | B-Cell Malignant Neoplasm | 1.21 | 60.4 | Medium confidence | pubmed | inputs
ranking row 2591285 |
| 115 | = | B-Cell Non-Hodgkin Lymphoma | 1.2 | 60 | Medium confidence | pubmed | inputs
ranking row 2591286 |
| 116 | = | Childhood Acute Lymphoblastic Leukemia | 1.2 | 59.6 | Medium confidence | pubmed | inputs
ranking row 2591287 |
| 117 | = | Malignant Skin Neoplasm | 1.2 | 59.3 | Medium confidence | pubmed | inputs
ranking row 2591288 |
| 118 | = | Invasive Malignant Neoplasm | 1.2 | 58.9 | Medium confidence | pubmed | inputs
ranking row 2591289 |
| 119 | = | Malignant Head and Neck Neoplasm | 1.19 | 58.6 | Medium confidence | pubmed | inputs
ranking row 2591290 |
| 120 | = | Malignant Vulvar Neoplasm | 1.19 | 58.2 | Medium confidence | pubmed | inputs
ranking row 2591291 |
| 121 | = | Malignant Penile Neoplasm | 1.18 | 57.9 | Medium confidence | pubmed | inputs
ranking row 2591292 |
| 122 | = | Mixed Germ Cell Tumor | 1.18 | 57.5 | Medium confidence | pubmed | inputs
ranking row 2591293 |
| 123 | = | Follicular Helper T-Cell Lymphoma | 1.18 | 57.2 | Medium confidence | pubmed | inputs
ranking row 2591294 |
| 124 | = | Adult B Acute Lymphoblastic Leukemia | 1.18 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2591295 |
| 125 | = | Acute Monocytic Leukemia | 1.17 | 56.5 | Medium confidence | pubmed | inputs
ranking row 2591296 |
| 126 | = | Malignant Ovarian Neoplasm | 1.17 | 56.1 | Medium confidence | pubmed | inputs
ranking row 2591297 |
| 127 | = | Splenic Hodgkin Lymphoma | 1.17 | 55.8 | Medium confidence | pubmed | inputs
ranking row 2591298 |
| 128 | = | Malignant Rectal Neoplasm | 1.16 | 55.4 | Medium confidence | pubmed | inputs
ranking row 2591299 |
| 129 | = | Malignant Central Nervous System Neoplasm | 1.16 | 55.1 | Medium confidence | pubmed | inputs
ranking row 2591300 |
| 130 | = | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1.16 | 54.7 | Medium confidence | pubmed | inputs
ranking row 2591301 |
| 131 | = | Malignant Laryngeal Neoplasm | 1.16 | 54.4 | Medium confidence | pubmed | inputs
ranking row 2591302 |
| 132 | = | Acute Leukemia | 1.16 | 54 | Medium confidence | pubmed | inputs
ranking row 2591303 |
| 133 | = | Malignant Thoracic Neoplasm | 1.15 | 53.7 | Medium confidence | pubmed | inputs
ranking row 2591304 |
| 134 | = | Skin Carcinoma | 1.15 | 53.3 | Medium confidence | pubmed | inputs
ranking row 2591305 |
| 135 | = | Malignant Soft Tissue Neoplasm | 1.15 | 53 | Medium confidence | pubmed | inputs
ranking row 2591306 |
| 136 | = | Malignant Oropharyngeal Neoplasm | 1.14 | 52.6 | Medium confidence | pubmed | inputs
ranking row 2591307 |
| 137 | = | Chronic Leukemia | 1.14 | 52.3 | Medium confidence | pubmed | inputs
ranking row 2591308 |
| 138 | = | Childhood Myelodysplastic Syndrome | 1.13 | 51.9 | Medium confidence | pubmed | inputs
ranking row 2591309 |
| 139 | = | Smoldering Multiple Myeloma | 1.13 | 51.6 | Medium confidence | pubmed | inputs
ranking row 2591310 |
| 140 | = | High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements | 1.13 | 51.2 | Medium confidence | pubmed | inputs
ranking row 2591311 |
| 141 | = | Primary Cutaneous Diffuse Large B-Cell Lymphoma | 1.12 | 50.9 | Medium confidence | pubmed | inputs
ranking row 2591312 |
| 142 | = | Malignant Thyroid Gland Neoplasm | 1.12 | 50.5 | Medium confidence | pubmed | inputs
ranking row 2591313 |
| 143 | = | Mediastinal Lymphoma | 1.12 | 50.2 | Medium confidence | pubmed | inputs
ranking row 2591314 |
| 144 | = | Malignant Testicular Neoplasm | 1.12 | 49.8 | Medium confidence | pubmed | inputs
ranking row 2591315 |
| 145 | = | Malignant Gastric Neoplasm | 1.12 | 49.5 | Medium confidence | pubmed | inputs
ranking row 2591316 |
| 146 | = | Malignant Esophageal Neoplasm | 1.11 | 49.1 | Medium confidence | pubmed | inputs
ranking row 2591317 |
| 147 | = | Malignant Salivary Gland Neoplasm | 1.11 | 48.8 | Medium confidence | pubmed | inputs
ranking row 2591318 |
| 148 | = | Childhood Hodgkin Lymphoma | 1.11 | 48.4 | Medium confidence | pubmed | inputs
ranking row 2591319 |
| 149 | = | Adult Acute Monocytic Leukemia | 1.11 | 48.1 | Medium confidence | pubmed | inputs
ranking row 2591320 |
| 149 | = | Childhood Acute Monocytic Leukemia | 1.11 | 48.1 | Medium confidence | pubmed | inputs
ranking row 2591321 |
| 151 | = | Adult Hodgkin Lymphoma | 1.11 | 47.4 | Medium confidence | pubmed | inputs
ranking row 2591322 |
| 152 | = | Cardiac Lymphoma | 1.1 | 47 | Medium confidence | pubmed | inputs
ranking row 2591323 |
| 153 | = | Malignant Lip and Oral Cavity Neoplasm | 1.1 | 46.7 | Medium confidence | pubmed | inputs
ranking row 2591324 |
| 154 | = | Cutaneous Melanoma | 1.1 | 46.3 | Medium confidence | pubmed | inputs
ranking row 2591325 |
| 155 | = | Lymphoid Neoplasm | 1.1 | 46 | Medium confidence | pubmed | inputs
ranking row 2591326 |
| 156 | = | Secondary Central Nervous System Lymphoma | 1.1 | 45.6 | Medium confidence | pubmed | inputs
ranking row 2591327 |
| 157 | = | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1.1 | 45.3 | Medium confidence | pubmed | inputs
ranking row 2591328 |
| 158 | = | Early T Precursor Acute Lymphoblastic Leukemia | 1.1 | 44.9 | Medium confidence | pubmed | inputs
ranking row 2591329 |
| 159 | = | Childhood Non-Hodgkin Lymphoma | 1.08 | 44.6 | Medium confidence | pubmed | inputs
ranking row 2591330 |
| 160 | = | Hepatoblastoma | 1.08 | 44.2 | Medium confidence | pubmed | inputs
ranking row 2591331 |
| 161 | = | Primary Cutaneous Lymphoma | 1.08 | 43.9 | Medium confidence | pubmed | inputs
ranking row 2591332 |
| 162 | = | Malignant Genitourinary System Neoplasm | 1.08 | 43.5 | Medium confidence | pubmed | inputs
ranking row 2591333 |
| 163 | = | Adult Non-Hodgkin Lymphoma | 1.07 | 43.2 | Medium confidence | pubmed | inputs
ranking row 2591334 |
| 164 | = | Malignant Kidney Neoplasm | 1.07 | 42.8 | Medium confidence | pubmed | inputs
ranking row 2591335 |
| 165 | = | Anaplastic Lymphoma | 1.07 | 42.5 | Medium confidence | pubmed | inputs
ranking row 2591336 |
| 166 | = | Cutaneous Lymphoma | 1.06 | 42.1 | Medium confidence | pubmed | inputs
ranking row 2591337 |
| 167 | = | Adult Primary Cutaneous Anaplastic Large Cell Lymphoma | 1.05 | 41.8 | Medium confidence | pubmed | inputs
ranking row 2591339 |
| 167 | = | AIDS-Related Lymphoma | 1.05 | 41.8 | Medium confidence | pubmed | inputs
ranking row 2591338 |
| 169 | = | Childhood Leukemia | 1.05 | 41.1 | Medium confidence | pubmed | inputs
ranking row 2591340 |
| 170 | = | Radiation-Related Malignant Neoplasm | 1.04 | 40.7 | Medium confidence | pubmed | inputs
ranking row 2591341 |
| 171 | = | Small Intestinal Lymphoma | 1.04 | 40.4 | Medium confidence | pubmed | inputs
ranking row 2591342 |
| 172 | = | Gray-Zone Lymphoma | 1.04 | 40 | Medium confidence | pubmed | inputs
ranking row 2591343 |
| 173 | = | Mature B-Cell Non-Hodgkin Lymphoma | 1.03 | 39.6 | Medium confidence | pubmed | inputs
ranking row 2591344 |
| 174 | = | Malignant Liver Neoplasm | 1.03 | 39.3 | Medium confidence | pubmed | inputs
ranking row 2591345 |
| 175 | = | Diffuse Large B-Cell Lymphoma Activated B-Cell Type | 1.03 | 38.9 | Medium confidence | pubmed | inputs
ranking row 2591346 |
| 176 | = | Myelodysplastic Syndrome with Excess Blasts | 1.02 | 38.6 | Medium confidence | pubmed | inputs
ranking row 2591347 |
| 177 | = | B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | 1.02 | 38.2 | Medium confidence | pubmed | inputs
ranking row 2591348 |
| 178 | = | Malignant Vaginal Neoplasm | 1.02 | 37.9 | Medium confidence | pubmed | inputs
ranking row 2591349 |
| 179 | = | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 1.01 | 37.5 | Medium confidence | pubmed | inputs
ranking row 2591350 |
| 180 | = | Malignant Myoepithelioma | 1.01 | 37.2 | Medium confidence | pubmed | inputs
ranking row 2591351 |
| 181 | = | Adult Myelodysplastic Syndrome | 1.01 | 36.8 | Medium confidence | pubmed | inputs
ranking row 2591352 |
| 182 | = | Pediatric-Type Follicular Lymphoma | 1.01 | 36.5 | Medium confidence | pubmed | inputs
ranking row 2591353 |
| 183 | = | Kidney Non-Hodgkin Lymphoma | 1 | 36.1 | Medium confidence | pubmed | inputs
ranking row 2591355 |
| 183 | = | Splenic Lymphoma | 1 | 36.1 | Medium confidence | pubmed | inputs
ranking row 2591354 |
| 185 | = | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | 35.4 | Medium confidence | pubmed | inputs
ranking row 2591356 |
| 186 | = | Malignant Pelvic Neoplasm | 0.99 | 35.1 | Medium confidence | pubmed | inputs
ranking row 2591357 |
| 187 | = | Gastric Lymphoma | 0.98 | 34.7 | Medium confidence | pubmed | inputs
ranking row 2591358 |
| 188 | = | Thyroid Gland Lymphoma | 0.97 | 34.4 | Medium confidence | pubmed | inputs
ranking row 2591359 |
| 189 | = | Childhood Anaplastic Large Cell Lymphoma | 0.97 | 34 | Medium confidence | pubmed | inputs
ranking row 2591360 |
| 190 | = | Adult Anaplastic Large Cell Lymphoma | 0.97 | 33.7 | Medium confidence | pubmed | inputs
ranking row 2591361 |
| 191 | = | Malignant Abdominal Neoplasm | 0.96 | 33.3 | Medium confidence | pubmed | inputs
ranking row 2591362 |
| 192 | = | Splenic Marginal Zone Lymphoma | 0.96 | 33 | Medium confidence | pubmed | inputs
ranking row 2591363 |
| 193 | = | Childhood B Acute Lymphoblastic Leukemia | 0.95 | 32.6 | Medium confidence | pubmed | inputs
ranking row 2591364 |
| 194 | = | Mediastinal Hodgkin Lymphoma | 0.95 | 32.3 | Medium confidence | pubmed | inputs
ranking row 2591365 |
| 195 | = | Primary Effusion Lymphoma | 0.94 | 31.9 | Medium confidence | pubmed | inputs
ranking row 2591366 |
| 196 | = | Multiple Myeloma | 0.94 | 31.6 | Medium confidence | pubmed | inputs
ranking row 2591367 |
| 197 | = | Myeloid Neoplasm Post Cytotoxic Therapy | 0.94 | 31.2 | Medium confidence | pubmed | inputs
ranking row 2591368 |
| 198 | = | Hepatosplenic T-Cell Lymphoma | 0.93 | 30.9 | Medium confidence | pubmed | inputs
ranking row 2591369 |
| 199 | = | Carcinoma | 0.91 | 30.5 | Medium confidence | pubmed | inputs
ranking row 2591370 |
| 200 | = | Acute Lymphoblastic Leukemia | 0.91 | 30.2 | Medium confidence | pubmed | inputs
ranking row 2591371 |
| 201 | = | Nodal Marginal Zone Lymphoma | 0.9 | 29.8 | Medium confidence | pubmed | inputs
ranking row 2591372 |
| 202 | = | Malignant Nasopharyngeal Neoplasm | 0.9 | 29.5 | Medium confidence | pubmed | inputs
ranking row 2591373 |
| 203 | = | Granulocytic Sarcoma | 0.9 | 29.1 | Medium confidence | pubmed | inputs
ranking row 2591374 |
| 204 | = | Malignant Eye Neoplasm | 0.9 | 28.8 | Medium confidence | pubmed | inputs
ranking row 2591375 |
| 205 | = | Subcutaneous Panniculitis-Like T-Cell Lymphoma | 0.89 | 28.4 | Medium confidence | pubmed | inputs
ranking row 2591376 |
| 206 | = | Primitive Neuroectodermal Tumor | 0.89 | 28.1 | Medium confidence | pubmed | inputs
ranking row 2591377 |
| 207 | = | Malignant Colon Neoplasm | 0.88 | 27.7 | Medium confidence | pubmed | inputs
ranking row 2591378 |
| 208 | = | Primary Bone Lymphoma | 0.88 | 27.4 | Medium confidence | pubmed | inputs
ranking row 2591379 |
| 209 | = | Adult T-Cell Leukemia/Lymphoma | 0.88 | 27 | Medium confidence | pubmed | inputs
ranking row 2591380 |
| 210 | = | Primary Myelofibrosis | 0.88 | 26.7 | Medium confidence | pubmed | inputs
ranking row 2591381 |
| 211 | = | Chronic Myelomonocytic Leukemia | 0.87 | 26.3 | Medium confidence | pubmed | inputs
ranking row 2591382 |
| 212 | = | Histiocytic Sarcoma | 0.87 | 26 | Medium confidence | pubmed | inputs
ranking row 2591383 |
| 213 | = | Malignant Solitary Fibrous Tumor | 0.87 | 25.6 | Medium confidence | pubmed | inputs
ranking row 2591384 |
| 214 | = | Acute Myeloid Leukemia | 0.87 | 25.3 | Medium confidence | pubmed | inputs
ranking row 2591385 |
| 215 | = | Chordoma | 0.86 | 24.9 | Medium confidence | pubmed | inputs
ranking row 2591386 |
| 216 | = | Indolent Adult Non-Hodgkin Lymphoma | 0.86 | 24.6 | Medium confidence | pubmed | inputs
ranking row 2591387 |
| 217 | = | Mantle Cell Lymphoma | 0.86 | 24.2 | Medium confidence | pubmed | inputs
ranking row 2591388 |
| 218 | = | Follicular Dendritic Cell Sarcoma | 0.86 | 23.9 | Medium confidence | pubmed | inputs
ranking row 2591389 |
| 219 | = | Myelodysplastic Syndrome | 0.86 | 23.5 | Medium confidence | pubmed | inputs
ranking row 2591390 |
| 220 | = | Chronic Eosinophilic Leukemia, Not Otherwise Specified | 0.85 | 23.2 | Medium confidence | pubmed | inputs
ranking row 2591391 |
| 221 | = | Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type | 0.85 | 22.8 | Medium confidence | pubmed | inputs
ranking row 2591392 |
| 222 | = | Myeloid Leukemia | 0.85 | 22.5 | Medium confidence | pubmed | inputs
ranking row 2591393 |
| 223 | = | Primary Intraocular Non-Hodgkin Lymphoma | 0.85 | 22.1 | Medium confidence | pubmed | inputs
ranking row 2591394 |
| 224 | = | Lymphoid Leukemia | 0.84 | 21.8 | Medium confidence | pubmed | inputs
ranking row 2591395 |
| 225 | = | Leukemia | 0.84 | 21.4 | Medium confidence | pubmed | inputs
ranking row 2591396 |
| 226 | = | Kaposi Sarcoma | 0.83 | 21.1 | Medium confidence | pubmed | inputs
ranking row 2591397 |
| 227 | = | Thyroid Gland Follicular Carcinoma | 0.82 | 20.7 | Medium confidence | pubmed | inputs
ranking row 2591398 |
| 228 | = | Sarcoma | 0.82 | 20.4 | Medium confidence | pubmed | inputs
ranking row 2591399 |
| 229 | = | Lymphoma | 0.81 | 20 | Medium confidence | pubmed | inputs
ranking row 2591400 |
| 230 | = | Polycythemia Vera | 0.81 | 19.6 | Medium confidence | pubmed | inputs
ranking row 2591401 |
| 231 | = | Nodular Lymphocyte Predominant B-Cell Lymphoma | 0.81 | 19.3 | Medium confidence | pubmed | inputs
ranking row 2591402 |
| 232 | = | Non-Hodgkin Lymphoma | 0.8 | 18.9 | Medium confidence | pubmed | inputs
ranking row 2591403 |
| 233 | = | Plasmablastic Lymphoma | 0.8 | 18.6 | Medium confidence | pubmed | inputs
ranking row 2591404 |
| 234 | = | Transient Abnormal Myelopoiesis Associated with Down Syndrome | 0.79 | 18.2 | Medium confidence | pubmed | inputs
ranking row 2591405 |
| 235 | = | Melanoma | 0.79 | 17.9 | Medium confidence | pubmed | inputs
ranking row 2591406 |
| 236 | = | Grade 3b Follicular Lymphoma | 0.79 | 17.5 | Medium confidence | pubmed | inputs
ranking row 2591407 |
| 237 | = | T Acute Lymphoblastic Leukemia | 0.79 | 17.2 | Medium confidence | pubmed | inputs
ranking row 2591408 |
| 238 | = | Breast Implant-Associated Anaplastic Large Cell Lymphoma | 0.78 | 16.8 | Medium confidence | pubmed | inputs
ranking row 2591409 |
| 239 | = | Follicular Lymphoma | 0.78 | 16.5 | Medium confidence | pubmed | inputs
ranking row 2591410 |
| 240 | = | Plasma Cell Leukemia | 0.77 | 16.1 | Medium confidence | pubmed | inputs
ranking row 2591411 |
| 241 | = | Waldenstrom Macroglobulinemia | 0.77 | 15.8 | Medium confidence | pubmed | inputs
ranking row 2591412 |
| 242 | = | Hodgkin Lymphoma | 0.77 | 15.4 | Medium confidence | pubmed | inputs
ranking row 2591413 |
| 243 | = | Myeloproliferative Neoplasm | 0.76 | 15.1 | Medium confidence | pubmed | inputs
ranking row 2591414 |
| 244 | = | Wilms Tumor | 0.76 | 14.7 | Medium confidence | pubmed | inputs
ranking row 2591415 |
| 245 | = | Liver Lymphoma | 0.76 | 14.4 | Medium confidence | pubmed | inputs
ranking row 2591416 |
| 245 | = | Primary Cutaneous Follicle Center Lymphoma | 0.76 | 14.4 | Medium confidence | pubmed | inputs
ranking row 2591417 |
| 247 | = | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 0.75 | 13.7 | Medium confidence | pubmed | inputs
ranking row 2591418 |
| 247 | = | Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 0.75 | 13.7 | Medium confidence | pubmed | inputs
ranking row 2591419 |
| 249 | = | T-Cell Large Granular Lymphocyte Leukemia | 0.75 | 13 | Medium confidence | pubmed | inputs
ranking row 2591420 |
| 250 | = | Mycosis Fungoides | 0.74 | 12.6 | Medium confidence | pubmed | inputs
ranking row 2591421 |
| 251 | = | Myelodysplastic/Myeloproliferative Neoplasm | 0.74 | 12.3 | Medium confidence | pubmed | inputs
ranking row 2591422 |
| 252 | = | Hairy Cell Leukemia Variant | 0.73 | 11.9 | Medium confidence | pubmed | inputs
ranking row 2591423 |
| 253 | = | Myeloid Sarcoma | 0.73 | 11.6 | Medium confidence | pubmed | inputs
ranking row 2591424 |
| 254 | = | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | 0.73 | 11.2 | Medium confidence | pubmed | inputs
ranking row 2591425 |
| 255 | = | Malignant Endocrine Neoplasm | 0.73 | 10.9 | Medium confidence | pubmed | inputs
ranking row 2591426 |
| 256 | = | Infant Acute Lymphoblastic Leukemia | 0.72 | 10.5 | Medium confidence | pubmed | inputs
ranking row 2591427 |
| 257 | = | Acute Erythroid Leukemia | 0.72 | 10.2 | Medium confidence | pubmed | inputs
ranking row 2591428 |
| 258 | = | Acute Megakaryoblastic Leukemia | 0.71 | 9.8 | Medium confidence | pubmed | inputs
ranking row 2591429 |
| 259 | = | Malignant Mesothelioma | 0.71 | 9.5 | Medium confidence | pubmed | inputs
ranking row 2591430 |
| 260 | = | Sezary Syndrome | 0.7 | 9.1 | Medium confidence | pubmed | inputs
ranking row 2591431 |
| 261 | = | T-Cell Non-Hodgkin Lymphoma | 0.7 | 8.8 | Medium confidence | pubmed | inputs
ranking row 2591432 |
| 262 | = | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 0.69 | 8.4 | Medium confidence | pubmed | inputs
ranking row 2591433 |
| 263 | = | Chronic Lymphocytic Leukemia | 0.69 | 8.1 | Medium confidence | pubmed | inputs
ranking row 2591434 |
| 264 | = | Erythroleukemia | 0.68 | 7.7 | Medium confidence | pubmed | inputs
ranking row 2591435 |
| 265 | = | Cerebral Lymphoma | 0.66 | 7.4 | Medium confidence | pubmed | inputs
ranking row 2591436 |
| 265 | = | Primary Cutaneous Gamma-Delta T-Cell Lymphoma | 0.66 | 7.4 | Medium confidence | pubmed | inputs
ranking row 2591437 |
| 267 | = | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 0.65 | 6.7 | Medium confidence | pubmed | inputs
ranking row 2591438 |
| 268 | = | Essential Thrombocythemia | 0.63 | 6.3 | Medium confidence | pubmed | inputs
ranking row 2591439 |
| 269 | = | Testicular Lymphoma | 0.63 | 6 | Medium confidence | pubmed | inputs
ranking row 2591440 |
| 270 | = | Adult Erythroleukemia | 0.62 | 5.6 | Medium confidence | pubmed | inputs
ranking row 2591441 |
| 271 | = | Juvenile Myelomonocytic Leukemia | 0.6 | 5.3 | Medium confidence | pubmed | inputs
ranking row 2591442 |
| 272 | = | Enteropathy-Associated T-Cell Lymphoma | 0.6 | 4.9 | Medium confidence | pubmed | inputs
ranking row 2591443 |
| 273 | = | Plasmacytoma | 0.6 | 4.6 | Medium confidence | pubmed | inputs
ranking row 2591444 |
| 274 | = | Parathyroid Cancer | 0.57 | 4.2 | Medium confidence | pubmed | inputs
ranking row 2591445 |
| 275 | = | Acute Monoblastic Leukemia | 0.56 | 3.9 | Medium confidence | pubmed | inputs
ranking row 2591446 |
| 276 | = | Acute Promyelocytic Leukemia | 0.56 | 3.5 | Medium confidence | pubmed | inputs
ranking row 2591447 |
| 277 | = | Hairy Cell Leukemia | 0.53 | 3.2 | Medium confidence | pubmed | inputs
ranking row 2591448 |
| 278 | = | T-Cell Prolymphocytic Leukemia | 0.52 | 2.8 | Medium confidence | pubmed | inputs
ranking row 2591449 |
| 279 | = | Burkitt Lymphoma | 0.5 | 2.5 | Medium confidence | pubmed | inputs
ranking row 2591451 |
| 279 | = | Pancreatic Lymphoma | 0.5 | 2.5 | Medium confidence | pubmed | inputs
ranking row 2591450 |
| 281 | = | Anaplastic Large Cell Lymphoma | 0.49 | 1.8 | Medium confidence | pubmed | inputs
ranking row 2591452 |
| 282 | = | Adult T Acute Lymphoblastic Leukemia | 0.49 | 1.4 | Medium confidence | pubmed | inputs
ranking row 2591453 |
| 283 | = | Prolymphocytic Leukemia | 0.46 | 1.1 | Medium confidence | pubmed | inputs
ranking row 2591454 |
| 284 | = | Infant T Acute Lymphoblastic Leukemia | 0.41 | 0.7 | Medium confidence | pubmed | inputs
ranking row 2591455 |
| 285 | = | Cytogenetically Normal Acute Myeloid Leukemia | 0.38 | 0.4 | Medium confidence | pubmed | inputs
ranking row 2591456 |
| 286 | = | Childhood T Acute Lymphoblastic Leukemia | 0.34 | 0 | Medium confidence | pubmed | inputs
ranking row 2591457 |
Data updated 16 hours agoSource updated unknown286 eligible entities · inputs hash 3385afecab0ace04e61b6db0